Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Amarantus Bioscience Holdings, Inc. | f10q0316_amarantusbio.htm |
| EX-32.1 - CERTIFICATION - Amarantus Bioscience Holdings, Inc. | f10q0316ex32i_amarantusbio.htm |
| EX-31.2 - CERTIFICATION - Amarantus Bioscience Holdings, Inc. | f10q0316ex31ii_amarantusbio.htm |
| EX-31.1 - CERTIFICATION - Amarantus Bioscience Holdings, Inc. | f10q0316ex31i_amarantusbio.htm |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Robert Farrell, the Chief Financial Officer of Amarantus BioScience Holdings, Inc. (the “Company”), hereby certify, that, to my knowledge:
1. The Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: June 1, 2016 | /s/ Robert Farrell |
| Robert Farrell | |
| Chief Financial Officer | |
| (Principal Financial Officer) |